Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by biotech1973on Jan 09, 2020 12:56pm
152 Views
Post# 30535159

RE:RE:Any news

RE:RE:Any news
If everything goes well and a partnership with upfront 50 Million for ryplazim. We should have 100 million in account by 4 months minus our burn and sales of 400 million a year. This can go to 2 billion cap plus minus 300 million. which is 100$ Maximum. Then if lazard closes PBI 4050 Partnership and We fast track PBi for Phase 3. This can go further 3 folds to 300-350$. But these are all Hypothetical figures but 100% justifiable. Honestly this will never happe because Thomvest will sell the company way before. I say 100$ by 1H if and only if everything goes well as expected which is Unlikely as well considering past BUT THEY WILL DO A DUE DELIGENCE before filing for Ryplazim this time. So there is a fair posibility that 100$ share price can be achieved by July
<< Previous
Bullboard Posts
Next >>